Clinical Trial Update: Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Wuling Powder for depressive symptoms in Parkinson's disease. The study also investigates potential underlying mechanisms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Drugs mentioned

• Wuling Powder

Snippet

Sponsor: Beijing Hospital | Conditions: Antidepressive Agents | Phase 4 | Status: UNKNOWN